A. Sticca

Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide

Paolo Angeli, Roberta Volpin, Giorgio Enrico Gerunda et al. · Hepatology · 1999 · 561 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Paolo Caraceni, Oliviero Riggio, Paolo Angeli et al. · The Lancet · 2018 · 514 citations · Full text

Medicine, Internal Medicine, Hepatology +9

Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features

Silvano Fasolato, Paolo Angeli, Lucia Dallagnese et al. · Hepatology · 2006 · 326 citations · Full text

Veterinary Medicine, Infectious Diseases, Nephrology +11

Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study

M. Cavallin, Salvatore Piano, Antonietta Romano et al. · Hepatology · 2015 · 315 citations

Medicine, Pharmacology, Pharmacotherapy +13

The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial

Salvatore Piano, Silvano Fasolato, Freddy Salinas et al. · Hepatology · 2015 · 244 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15